CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis

NYSE:CPT • US1331311027

108.53 USD
+1.05 (+0.98%)
At close: Feb 13, 2026
108.53 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, CPT scores 3 out of 10 in our fundamental rating. CPT was compared to 20 industry peers in the Residential REITs industry. CPT has a medium profitability rating, but doesn't score so well on its financial health evaluation. CPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • CPT had positive earnings in the past year.
  • In the past year CPT had a positive cash flow from operations.
  • CPT had positive earnings in 4 of the past 5 years.
  • CPT had a positive operating cash flow in 4 of the past 5 years.
CPT Yearly Net Income VS EBIT VS OCF VS FCFCPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • CPT has a Return On Assets of 2.97%. This is comparable to the rest of the industry: CPT outperforms 55.00% of its industry peers.
  • CPT has a Return On Equity of 5.92%. This is comparable to the rest of the industry: CPT outperforms 55.00% of its industry peers.
  • CPT's Return On Invested Capital of 2.64% is in line compared to the rest of the industry. CPT outperforms 55.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROIC 2.64%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
CPT Yearly ROA, ROE, ROICCPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • CPT's Profit Margin of 17.11% is in line compared to the rest of the industry. CPT outperforms 50.00% of its industry peers.
  • CPT's Profit Margin has declined in the last couple of years.
  • CPT has a Operating Margin (18.25%) which is comparable to the rest of the industry.
  • CPT's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 61.28%, CPT is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CPT has remained more or less at the same level.
Industry RankSector Rank
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
CPT Yearly Profit, Operating, Gross MarginsCPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPT is destroying value.
  • CPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CPT Yearly Shares OutstandingCPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CPT Yearly Total Debt VS Total AssetsCPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 1.60, we must say that CPT is in the distress zone and has some risk of bankruptcy.
  • CPT has a Altman-Z score of 1.60. This is in the better half of the industry: CPT outperforms 75.00% of its industry peers.
  • The Debt to FCF ratio of CPT is 9.72, which is on the high side as it means it would take CPT, 9.72 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CPT (9.72) is better than 95.00% of its industry peers.
  • A Debt/Equity ratio of 0.82 indicates that CPT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.82, CPT is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Altman-Z 1.6
ROIC/WACC0.36
WACC7.29%
CPT Yearly LT Debt VS Equity VS FCFCPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • CPT has a Current Ratio of 0.07. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CPT has a Current ratio of 0.07. This is amonst the worse of the industry: CPT underperforms 80.00% of its industry peers.
  • A Quick Ratio of 0.07 indicates that CPT may have some problems paying its short term obligations.
  • CPT has a worse Quick ratio (0.07) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
CPT Yearly Current Assets VS Current LiabilitesCPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.43% over the past year.
  • Measured over the past years, CPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.19% on average per year.
EPS 1Y (TTM)65.43%
EPS 3Y-18.05%
EPS 5Y20.19%
EPS Q2Q%289.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%

3.2 Future

  • CPT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.93% yearly.
  • Based on estimates for the next years, CPT will show a small growth in Revenue. The Revenue will grow by 4.18% on average per year.
EPS Next Y-61.19%
EPS Next 2Y-31.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.57%
Revenue Next 2Y2.57%
Revenue Next 3Y4.87%
Revenue Next 5Y4.18%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
CPT Yearly Revenue VS EstimatesCPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
CPT Yearly EPS VS EstimatesCPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 34.90, which means the current valuation is very expensive for CPT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPT is on the same level as its industry peers.
  • CPT is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 89.92, CPT can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CPT.
  • When comparing the Price/Forward Earnings ratio of CPT to the average of the S&P500 Index (28.06), we can say CPT is valued expensively.
Industry RankSector Rank
PE 34.9
Fwd PE 89.92
CPT Price Earnings VS Forward Price EarningsCPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 70.00% of the companies in the same industry are more expensive than CPT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CPT is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 30.02
EV/EBITDA 17.1
CPT Per share dataCPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • CPT's earnings are expected to decrease with -31.93% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.73
EPS Next 2Y-31.93%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • CPT has a Yearly Dividend Yield of 3.94%. Purely for dividend investing, there may be better candidates out there.
  • With a Dividend Yield of 3.94, CPT pays less dividend than the industry average, which is at 41.48. 80.00% of the companies listed in the same industry pay a better dividend than CPT!
  • Compared to an average S&P500 Dividend Yield of 1.82, CPT pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.94%

5.2 History

  • The dividend of CPT has a limited annual growth rate of 4.99%.
  • CPT has paid a dividend for at least 10 years, which is a reliable track record.
  • CPT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
CPT Yearly Dividends per shareCPT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • 170.91% of the earnings are spent on dividend by CPT. This is not a sustainable payout ratio.
  • The Dividend Rate of CPT has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP170.91%
EPS Next 2Y-31.93%
EPS Next 3YN/A
CPT Yearly Income VS Free CF VS DividendCPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPT Dividend Payout.CPT Dividend Payout, showing the Payout Ratio.CPT Dividend Payout.PayoutRetained Earnings

CAMDEN PROPERTY TRUST

NYSE:CPT (2/13/2026, 8:04:00 PM)

After market: 108.53 0 (0%)

108.53

+1.05 (+0.98%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners98.17%
Inst Owner Change-1.34%
Ins Owners1.25%
Ins Owner Change0.72%
Market Cap11.55B
Revenue(TTM)N/A
Net Income(TTM)268.55M
Analysts71.03
Price Target117.88 (8.62%)
Short Float %3.75%
Short Ratio2.75
Dividend
Industry RankSector Rank
Dividend Yield 3.94%
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP170.91%
Div Incr Years7
Div Non Decr Years14
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)121.26%
Min EPS beat(2)-0.59%
Max EPS beat(2)243.11%
EPS beat(4)2
Avg EPS beat(4)58.98%
Min EPS beat(4)-12.31%
Max EPS beat(4)243.11%
EPS beat(8)4
Avg EPS beat(8)90.86%
EPS beat(12)8
Avg EPS beat(12)76.46%
EPS beat(16)9
Avg EPS beat(16)99.25%
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-1.04%
Revenue beat(12)0
Avg Revenue beat(12)-0.97%
Revenue beat(16)2
Avg Revenue beat(16)5.1%
PT rev (1m)-0.32%
PT rev (3m)-4.62%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)11.7%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)46.98%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 34.9
Fwd PE 89.92
P/S 7.36
P/FCF 30.02
P/OCF 14.76
P/B 2.55
P/tB 2.55
EV/EBITDA 17.1
EPS(TTM)3.11
EY2.87%
EPS(NY)1.21
Fwd EY1.11%
FCF(TTM)3.62
FCFY3.33%
OCF(TTM)7.35
OCFY6.77%
SpS14.75
BVpS42.63
TBVpS42.63
PEG (NY)N/A
PEG (5Y)1.73
Graham Number54.62
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROCE 3.34%
ROIC 2.64%
ROICexc 2.65%
ROICexgc 2.73%
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
FCFM 24.51%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexgc growth 3Y0.86%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Debt/EBITDA 4.19
Cap/Depr 65.56%
Cap/Sales 25.33%
Interest Coverage 2.06
Cash Conversion 87.62%
Profit Quality 143.24%
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 1.6
F-Score5
WACC7.29%
ROIC/WACC0.36
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)65.43%
EPS 3Y-18.05%
EPS 5Y20.19%
EPS Q2Q%289.19%
EPS Next Y-61.19%
EPS Next 2Y-31.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%
Revenue Next Year1.57%
Revenue Next 2Y2.57%
Revenue Next 3Y4.87%
Revenue Next 5Y4.18%
EBIT growth 1Y-5.72%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year209.25%
EBIT Next 3Y47.5%
EBIT Next 5Y37.45%
FCF growth 1Y3.98%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.43%
OCF growth 3Y10.3%
OCF growth 5Y6.88%

CAMDEN PROPERTY TRUST / CPT FAQ

What is the fundamental rating for CPT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CPT.


What is the valuation status of CAMDEN PROPERTY TRUST (CPT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMDEN PROPERTY TRUST (CPT). This can be considered as Overvalued.


Can you provide the profitability details for CAMDEN PROPERTY TRUST?

CAMDEN PROPERTY TRUST (CPT) has a profitability rating of 4 / 10.


How financially healthy is CAMDEN PROPERTY TRUST?

The financial health rating of CAMDEN PROPERTY TRUST (CPT) is 3 / 10.


What is the expected EPS growth for CAMDEN PROPERTY TRUST (CPT) stock?

The Earnings per Share (EPS) of CAMDEN PROPERTY TRUST (CPT) is expected to decline by -61.19% in the next year.